Voxel-based morphometry to detect effect of APOE on brain gray matter changes in Parkinson's Disease

The goal of the study was to determine association between APOE Ɛ4 and gray matter changes in PD patients, with or without dementia. Twenty-five PD patients with the APOE Ɛ4 (13 with dementia), 24 without Ɛ4 (12 with dementia), and 26 controls were selected. We found no significant differences between PD patients and controls, or between PD patients with and without the APOE Ɛ4 allele, with regard to VBM analysis. Our results provide no evidence of an association of the APOE Ɛ4 and gray matter degenerative changes in patients with PD, either with or without dementia.